Longwood Capital Partners
3
38M
2
0.33
1
- Areas of investment
Summary
The venture was found in North America in United States. The leading representative office of defined VC is situated in the Portola Valley.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Outlook Therapeutics. Among the most popular fund investment industries, there are Pharmaceutical, Biopharma.
The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2015.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Longwood Capital Partners, startups are often financed by venBio Partners, Perceptive Advisors, Cormorant Global Healthcare Master Fund. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Perceptive Advisors, Cormorant Global Healthcare Master Fund. In the next rounds fund is usually obtained by venBio Partners, Sabby Management, Perceptive Advisors.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Pharmaceutical (2)
- Therapeutics (2)
- Biopharma (2)
- Life Science (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lassen Therapeutics | 19 Dec 2023 | Biotechnology, Life Science | Early Stage Venture | 85M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.